All results
2 results
-
INHALE
INHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the…
- Ages
- 4 Years - 17 Years
- Sexes
- All
-
Solid - SGT - 001
This is a controlled, open-label, single-ascending dose study to evaluate the safety, tolerability and efficacy of SGT-001 in adolescents and children with…
- Ages
- 4 Years - 17 Years
- Sexes
- Male